Publications:

Targeted sequencing reveals the mutational landscape responsible for sorafenib therapy in advanced hepatocellular carcinoma.

Theranostics

Tang, Jing J; Sui, Cheng-Jun CJ; Wang, Dong-Fang DF; Lu, Xin-Yuan XY; Luo, Gui-Juan GJ; Zhao, Qing Q; Lian, Qiu-Yu QY; Jeong, Seogsong S; Lin, Xi-Meng XM; Zhu, Yan-Jing YJ; Zheng, Bo B; Wu, Rui R; Wang, Qing Q; Liu, Xiao-Long XL; Liu, Jing-Feng JF; Xia, Qiang Q; Wu, Gang G; Gu, Jin J; Wang, Hong-Yang HY; Chen, Lei L

Publication Date: 2020

Variant appearance in text: HR: G52C

PubMed Link: 32373219

Variant Present in the following documents:

• Main text
• thnov10p5384.pdf

View BVdb publication page

Stepwise visualization of membrane pore formation by suilysin, a bacterial cholesterol-dependent cytolysin.

Elife

Leung, Carl C; Dudkina, Natalya V NV; Lukoyanova, Natalya N; Hodel, Adrian W AW; Farabella, Irene I; Pandurangan, Arun P AP; Jahan, Nasrin N; Pires Damaso, Mafalda M; Osmanović, Dino D; Reboul, Cyril F CF; Dunstone, Michelle A MA; Andrew, Peter W PW; Lonnen, Rana R; Topf, Maya M; Saibil, Helen R HR; Hoogenboom, Bart W BW

Publication Date: 2014-12-02

Variant appearance in text: HR: Gly52Cys

PubMed Link: 25457051

Variant Present in the following documents:

• elife04247.pdf

View BVdb publication page